Sign in
IPHA Stock Price, Chart, Stats & News
Innate Pharma S.A.
Save
168.09M
Market cap
–
Current P/E
–
Forward P/E
IPHA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -262.41% |
Operating margin | -969.38% |
Pretax margin | -870.76% |
Net margin | -820.60% |
Effective tax rate | 5.76% |
ROA | -78.11% |
ROE | 591.77% |
D/E | -1.04x |
Interest coverage ratio | -20.16x |
IPHA valuation
P/E | – |
P/S | 17.70x |
P/B | -4.75x |
P/CF | -1.89x |
P/FCF | -1.93x |
P/OCF | -1.89x |
PEG | -0.67x |
EV multiple | -1.99x |
About
Innate Pharma S. A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. The company primarily targets oncology indications across France and internationally, with some programs also addressing inflammatory diseases and viral infections.
Similar securities
Based on sector and market capitalization
Report issue